Mail icon

Vaccine development: reconciling sterility with efficiency

5 July, 2022 | ChargePoint Technology

Growth in the vaccination market has skyrocketed in recent years with the onset of the Covid 19 pandemic. Vaccine spending in the last year was higher than any other on record and forecasters are predicting that spending on the COVID-19 vaccine alone will reach $157 billion by 2025.

 

With the success of the COVID-19 vaccine fresh in people’s minds, many pharma leaders are beginning to look ahead to the future and see whether it will be possible to replicate the same success in the years to come. Ben Wylie (Senior Product Manager at ChargePoint Technology) discusses what the pharmaceutical industry can learn from the vaccine roll-out to achieve a similar balance of speed and efficiency whilst ensuring they maintain a sterile processing environment in the future.

 

Read the full article on Pharma Manufacturing.

 

Related articles